Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk.

Mateo, I; Infante, J; Rodríguez, E; Berciano, J; Combarros, O; Llorca, J

Mateo, I; Infante, J; Rodríguez, E; Berciano, J; Combarros, O; Llorca, J.

J Neurol Neurosurg Psychiatry ; 77(2): 278-9, 2006 Feb.

Article in En | MEDLINE | ID: mdl-16421143

Subject(s)

Alzheimer Disease/genetics; Dopamine beta-Hydroxylase/genetics; Epistasis, Genetic; Interleukin-1/genetics; Interleukin-6/genetics; Aged; Aged, 80 and over; Amyloid beta-Peptides/metabolism; Cerebral Cortex/enzymology; Dopamine/metabolism; Female; Genotype; Humans; Male; Middle Aged; Norepinephrine/metabolism; Polymorphism, Genetic/genetics; Risk

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-6 / Interleukin-1 / Dopamine beta-Hydroxylase / Epistasis, Genetic / Alzheimer Disease Type of study: Etiology_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2006 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google